Population-wide emergence of antiviral resistance during pandemic influenza
about
Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugsOptimizing treatment regimes to hinder antiviral resistance in influenza across time scalesThe use of mathematical models to inform influenza pandemic preparedness and response.Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.Intervention strategies for an influenza pandemic taking into account secondary bacterial infectionsAge-prioritized use of antivirals during an influenza pandemic.Estimated impact of aggressive empirical antiviral treatment in containing an outbreak of pandemic influenza H1N1 in an isolated First Nations community.Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.Antiviral prophylaxis during pandemic influenza may increase drug resistance.Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.Modelling an influenza pandemic: A guide for the perplexed.Home educating in an extended family culture and aging society may fare best during a pandemicModelling mitigation strategies for pandemic (H1N1) 2009.Post-exposure prophylaxis during pandemic outbreaksInfluenza mixes its pitches: Lessons learned to date from the influenza A (H1N1) pandemicStrategies for the use of oseltamivir and zanamivir during pandemic outbreaks.The role of cellular immunity in influenza H1N1 population dynamics.Paradox of vaccination: is vaccination really effective against avian flu epidemics?Modelers' perception of mathematical modeling in epidemiology: a web-based survey.Public health interventions for epidemics: implications for multiple infection waves.How to minimize the attack rate during multiple influenza outbreaks in a heterogeneous population.Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics.Optimality of a time-dependent treatment profile during an epidemic.Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategiesPopulation dynamics of epidemic and endemic states of drug-resistance emergence in infectious diseases.Can treatment increase the epidemic size?Impact of imitation processes on the effectiveness of ring vaccination.Managing public health crises: the role of models in pandemic preparednessOptimal antiviral treatment strategies and the effects of resistance.Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.Mathematical epidemiology: Past, present, and futureEmergence and spread of drug resistant influenza: A two-population game theoretical modelManaging the emergence of pathogen resistance via spatially targeted antimicrobial use
P2860
Q28472846-280AE525-CE39-4557-B8CB-C93B77C50C5AQ28485862-9E420FCD-4C80-41FF-B397-87C02C72637CQ30226500-BC7AB3A4-78E5-4E3D-967A-21D837C01301Q30226721-F4805BC4-E185-4484-8331-D98139D7B023Q30227297-E54A0A8D-50A7-4176-9E80-B8E9EB7DAA37Q30227718-41385FCF-4081-4C85-A2DC-C7D75CAEC1D8Q30352284-86734B01-D922-4138-97B9-73E1F1DAE858Q30372938-A2B6714E-457C-4A3B-A721-DA2317085A63Q30374442-2EA14027-E77B-4FF5-8328-943C0BA72C49Q30374475-20680CED-358B-4F3B-AA24-A0F4F71B535BQ30379091-F13AAB84-11DD-4B5C-9AE7-A4930808EA59Q30381103-5536BDE3-BD0A-4CB9-80C8-B0F6EC74FD8FQ30381617-CC293E0C-81D1-4475-B5F4-A3B2C2592FE5Q30383105-F85D19B4-38A4-4CF9-B674-48D6151DFC62Q30393202-EA33A5C3-643E-4432-AE88-AF3C43CD702CQ30400232-154265D0-E7BE-49FD-BBE6-89BD28C56AA0Q30424181-52C74AC0-4624-412B-BDA9-FD0A9C737C93Q33419383-A593DAFB-AECF-4D69-8363-C751CC96EAD3Q33815673-134D9CB1-55C2-4774-87F4-2ABA3F9F1FAFQ33831152-C58EEAD6-E5B9-468B-BF0F-E7D155D254B8Q34305125-F6F4686A-1BFC-4006-A719-8C71C9879028Q34580194-B96FB484-2F42-4C06-BC57-7D873FF278DBQ37122154-8BCB4DD6-69D3-40F8-9000-401CCFD455BAQ38633113-13806E51-896E-49F1-A672-5FBF2BD59877Q40368149-7CD7BAA2-DE17-4451-A847-8C3FB2A6B467Q40997093-CD49B9DE-E377-4BC4-81F9-EA70ACF65EABQ42202634-70811583-215C-4533-B628-1F0EABCBFA9CQ42592367-98D72038-E94D-40DF-B332-382C16D56608Q51653188-8737F3B6-B952-45A7-B057-040AD4640006Q55499955-FE820413-B78F-4CC4-ADAD-2AA037748795Q56000783-E981D12F-FD8A-4449-8F42-797E6D6AA8EAQ57096132-FE0016E4-F8C3-4453-A799-A89B86046FFEQ59136516-D8EC4E54-1E55-49B7-A28A-CE8D3F029531
P2860
Population-wide emergence of antiviral resistance during pandemic influenza
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Population-wide emergence of antiviral resistance during pandemic influenza
@ast
Population-wide emergence of antiviral resistance during pandemic influenza
@en
Population-wide emergence of antiviral resistance during pandemic influenza
@nl
type
label
Population-wide emergence of antiviral resistance during pandemic influenza
@ast
Population-wide emergence of antiviral resistance during pandemic influenza
@en
Population-wide emergence of antiviral resistance during pandemic influenza
@nl
prefLabel
Population-wide emergence of antiviral resistance during pandemic influenza
@ast
Population-wide emergence of antiviral resistance during pandemic influenza
@en
Population-wide emergence of antiviral resistance during pandemic influenza
@nl
P2093
P2860
P1433
P1476
Population-wide emergence of antiviral resistance during pandemic influenza
@en
P2093
Christopher S Bowman
Jianhong Wu
Seyed M Moghadas
P2860
P356
10.1371/JOURNAL.PONE.0001839
P407
P50
P577
2008-03-19T00:00:00Z